Claret Asset Management Corp Eli Lilly & CO Transaction History

Claret Asset Management Corp

$611 Million
Q3 2024

A detailed history of Claret Asset Management Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Claret Asset Management Corp holds 424 shares of LLY stock, worth $325,530. This represents 0.06% of its overall portfolio holdings.

Number of Shares

424

Previous 424 -0.0%

Holding current value

$325,530

Previous $384,000 2.08%

% of portfolio

0.06%

Previous 0.07%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $50,740 - $63,632	-70 Reduced 14.17%	424 $384,000
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $8,403 - $9,906	16 Added 3.35%	494 $288,000
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $6,955 - $9,588	-16 Reduced 3.24%	478 $257,000
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $173,265 - $231,676	494 New	494 $232,000
Q1 2020 Apr 06, 2020	SELL	$119.05 - $147.35 $3.53 Million - $4.37 Million	-29,675 Closed	0 $0
Q4 2019 Jan 07, 2020	BUY	$106.92 - $132.43 $122,423 - $151,632	1,145 Added 4.01%	29,675 $3.9 Million
Q3 2019 Oct 11, 2019	SELL	$106.79 - $116.16 $9,077 - $9,873	-85 Reduced 0.3%	28,530 $3.19 Million
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $72,567 - $84,704	-655 Reduced 2.24%	28,615 $3.17 Million
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $44,524 - $52,408	-400 Reduced 1.35%	29,270 $3.8 Million
Q4 2018 Feb 07, 2019	SELL	$105.9 - $118.64 $120,514 - $135,012	-1,138 Reduced 3.69%	29,670 $3.43 Million
Q3 2018 Oct 30, 2018	SELL	$85.86 - $107.31 $30,909 - $38,631	-360 Reduced 1.16%	30,808 $3.31 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $59,803 - $68,635	790 Added 2.6%	31,168 $2.66 Million
Q1 2018 May 08, 2018	SELL	$74.21 - $87.6 $4,452 - $5,256	-60 Reduced 0.2%	30,378 $2.35 Million
Q4 2017 Mar 27, 2018	BUY	$81.94 - $87.89 $2.49 Million - $2.68 Million	30,438	30,438 $2.57 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.

Account

Claret Asset Management Corp Eli Lilly & CO Transaction History